ONCOIMMUNE INC

Basic Information

1275 KINNEAR RD
COLUMBUS, OH, 43212-1155

http://www.oncoimmune.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 146678516
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 2


  1. Targeting endogenous sialidases for treatment of endotoxic shock

    Amount: $395,408.00

    DESCRIPTION (provided by applicant): Despite the advance of antibiotics, sepsis remains a major challenge to human health as both survival and incidence of severe sepsis have been largely unchanged in ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Targeting host response to DAMP for therapy of Rheumatoid Arthritis

    Amount: $150,153.00

    DESCRIPTION (provided by applicant): Rheumatoid arthritis (RA) is among the most common autoimmune diseases. The current treatment for RA is mainly by targeting tumor-necrosis factor (TNF). Despite th ...

    SBIR Phase I 2011 Department of Health and Human Services
  3. Novel Therapeutics for Sepsis

    Amount: $155,180.00

    DESCRIPTION (provided by applicant): Sepsis is one of the top leading causes of deaths for Americans and it is responsible for approximately 200,000 deaths in US annually. Despite of the advance of an ...

    SBIR Phase I 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government